TC
AGTC

Telemus Capital’s Applied Genetic Technologies Corporation AGTC Stock Holding History

Telemus Capital’s Portfolio AGTC Stock Details AGTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-10,000
Closed -$50K – 396
2021
Q1 		$50K Buy
+10,000
New +$51.9K ﹤0.01% 385

Other funds holding AGTC

Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Telemus Capital's AGTC Position: Q2 2021 in Review

Telemus Capital sold out of Applied Genetic Technologies Corporation (AGTC) in Q2 2021, closing a stake of 10,000 shares — an estimated $50K sold.

Telemus Capital first reported a position in AGTC in Q1 2021 and held it in 1 quarter. The position peaked at $50K in Q1 2021. 71 funds tracked by Wall St. Rank hold AGTC as of Q2 2021.

  • Telemus Capital reported no remaining Applied Genetic Technologies Corporation position as of Q2 2021 after selling out during the quarter.
  • Telemus Capital sold 10,000 Applied Genetic Technologies Corporation shares in Q2 2021, an estimated $50K.
  • Telemus Capital first reported a position in Applied Genetic Technologies Corporation in Q1 2021 and held it in 1 quarter.
  • Telemus Capital's Applied Genetic Technologies Corporation position peaked at $50K in Q1 2021.
  • 71 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q2 2021.

Based on Telemus Capital's 13F filing for Q2 2021, filed 9 Aug 2021.